423 related articles for article (PubMed ID: 26796399)
1. A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.
Francis GS; Felker GM; Tang WH
J Am Coll Cardiol; 2016 Jan; 67(3):330-7. PubMed ID: 26796399
[TBL] [Abstract][Full Text] [Related]
2. [Natriuretic peptides--new diagnostic markers in heart disease].
Angermann CE; Ertl G
Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
[TBL] [Abstract][Full Text] [Related]
3. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
Ibrahim N; Januzzi JL
Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
[TBL] [Abstract][Full Text] [Related]
4. [Measurement of natriuretic peptides in heart failure: the good laboratory and clinical practice].
Kovács LG; Nyolczas N; Habon T; Sepp R; Piroth Z; Hajas Á; Boncz I; Tomcsányi J; Kappelmayer J; Merkely B
Orv Hetil; 2015 Aug; 156(31):1235-45. PubMed ID: 26211747
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides in the diagnosis and management of acute heart failure.
Mohammed AA; Januzzi JL
Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management.
Iwaz JA; Maisel AS
Expert Rev Mol Diagn; 2016 Jun; 16(6):641-50. PubMed ID: 26919295
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptides in heart failure and acute coronary syndrome.
Gaggin HK; Januzzi JL
Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
[TBL] [Abstract][Full Text] [Related]
8. [Natriuretic peptides in heart failure].
Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C
G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.
Clerico A; Passino C; Franzini M; Emdin M
Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871
[TBL] [Abstract][Full Text] [Related]
10. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure.
Gruson D; Ahn SA; Rousseau MF
Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic Peptides in Clinical Practice.
Çavuşoğlu Y; Alper AT; Altay H; Çelik A; Demirkan B; Güvenç TS; Küçükoğlu MS; Nalbantgil S; Özdemir M; Özin B; Sayın T; Yıldırımtürk Ö; Yılmaz MB; Zorkun C
Anatol J Cardiol; 2019 Mar; 21(Suppl 1):1-40. PubMed ID: 30860204
[TBL] [Abstract][Full Text] [Related]
12. [Place of natriuretic peptides in the early diagnosis of heart failure in community medicine].
Galinier M; Cariou E; Lairez O; Fournier P; Delmas C; Biendel-Picquet C; Roncalli J
Presse Med; 2018 Sep; 47(9):804-810. PubMed ID: 30293850
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
Bhardwaj A; Januzzi JL
Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
[TBL] [Abstract][Full Text] [Related]
14. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
[TBL] [Abstract][Full Text] [Related]
15. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
Omland T
Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
17. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
[TBL] [Abstract][Full Text] [Related]
18. Evolution of natriuretic peptide biomarkers in heart failure: Implications for clinical care and clinical trials.
Vodovar N; Mebazaa A; Januzzi JL; Murtagh G; Stough WG; Adams KF; Zannad F
Int J Cardiol; 2018 Mar; 254():215-221. PubMed ID: 29407093
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptide testing in clinical medicine.
Rehman SU; Januzzi JL
Cardiol Rev; 2008; 16(5):240-9. PubMed ID: 18708825
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides in the diagnosis and management of chronic heart failure.
Boerrigter G; Costello-Boerrigter LC; Burnett JC
Heart Fail Clin; 2009 Oct; 5(4):501-14. PubMed ID: 19631175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
